Scinai Immunotherapeutics annual revenue
2022
2023
2024
2025
Scinai Immunotherapeutics Revenue Growth & History (SCNI)
Scinai Immunotherapeutics reported $1.3M in revenue for fiscal 2025, an increase of 336917.99% from the previous fiscal year.
View full Scinai Immunotherapeutics company overviewScinai Immunotherapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.3M | $1.3M | +336917.99% |
| 2024 | 2024-12-31 | $389 | $389 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | — | — |
Scinai Immunotherapeutics quarterly revenue
Q4.24
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $460,000 | $273,000 | +145.99% |
| Q1 2026 | 2026-03-31 | $489,000 | −$97,000 | −16.55% |
| Q2 2025 | 2025-06-30 | $187,000 | — | — |
| Q1 2025 | 2025-03-31 | $586,000 | — | — |
| Q4 2024 | 2024-12-31 | $206,000 | — | — |
Scinai Immunotherapeutics revenue growth trends
Scinai Immunotherapeutics's latest reported quarter, Q2 2026, generated $460,000 in revenue, an increase of 145.99% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Scinai Immunotherapeutics source filings ↗